Table 1 Patient’s characteristics and pathological findings
Characteristic | All patients (n = 139) | EHCC (n = 89) | GB (n = 30) | IHCC (n = 20) | Control (n = 16) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
No. of patients | % | No. of patients | % | No. of patients | % | No. of patients | % | No. of patients | % | |
Median age (years) | 71 | 71 | 74 | 64 | 62 | |||||
Male | 86 | 61.8 | 65 | 73.0 | 8 | 26.7 | 13 | 65.0 | NA | |
R0 resection | 67 | 48.2 | 38 | 42.7 | 19 | 47.4 | 10 | 50.0 | NA | |
Poorly differentiated | 33 | 23.7 | 18 | 20.2 | 3 | 10.0 | 12 | 60.0 | NA | |
Lymphatic permeation | 111 | 79.8 | 74 | 83.1 | 23 | 76.7 | 14 | 70.0 | NA | |
Vascular invasion | 93 | 66.9 | 66 | 74.1 | 16 | 53.3 | 12 | 60.0 | NA | |
Lymph node metastases | 62 | 44.6 | 41 | 46.1 | 11 | 36.7 | 10 | 50.0 | NA | |
UICC p-stage | Â | Â | Â | Â | Â | |||||
 1 | 40 | 28.7 | 23 | 25.8 | 12 | 40.0 | 5 | 25.0 | NA | |
 2 | 70 | 50.4 | 49 | 55.1 | 12 | 40.0 | 9 | 45.0 | ||
 3 | 16 | 11.5 | 8 | 9.0 | 5 | 16.7 | 3 | 15.0 | ||
 4 | 13 | 9.4 | 9 | 10.1 | 1 | 3.3 | 3 | 15.0 | ||
Papillary morphology | 32 | 23.0 | 13 | 14.6 | 18 | 60.0 | 1 | 5.0 | NA | |
Adjuvant chemotherapy | 51 | 36.7 | 34 | 38.2 | 8 | 26.7 | 9 | 45.0 | NA | |
CEA (high) | 65 | 46.7 | 46 | 51.7 | 12 | 40.0 | 7 | 35.0 | NA | |
CA19-9 (high) | 66 | 47.5 | 44 | 49.4 | 12 | 40.0 | 10 | 50.0 | NA | |
LAT1 (high) | 89 | 64.0 | 59 | 66.3 | 18 | 60.0 | 12 | 60.0 | 0 | 0.0% |
Ki-67 (high) | 62 | 44.6 | 43 | 48.3 | 13 | 43.3 | 6 | 30.0 | 0 | 0.0% |
CD34 (high) | 69 | 49.6 | 46 | 51.7 | 14 | 46.7 | 9 | 45.0 | 0 | 0.0% |
p53 (positive) | 71 | 51.1 | 44 | 49.4 | 20 | 66.7 | 7 | 35.0 | 0 | 0.0% |